Lifeclinic: Blood Pressure Monitors & Health Stations
HomeBlood PressureCholesterolDiabetesNutritionSenior Care
Key Word Search
 
Basic Facts
How to Lower It
Monitoring Your BP
Visiting Your Doctor
Risk Factors
Low Blood Pressure
Hypertension & Pregnancy
Stroke
Heart Failure
My Health Record
FREE
Blood Pressure Health Station Locator
Locate a Dealer
Resources
Cookbook
Hypertension Dictionary
Health News
Reminders
My Saved Articles
Links
About Us
Contact Us
Press Releases
Advertising
Terms of Use
Privacy Policy
 

Aceon (perindopril), a new ACE inhibitor

By: Thomas Pickering, MD, DPhil, FRCP, Director of Integrative and Behavioral Cardiology Program
of the Cardiovascular Institute at Mount Sinai School of Medicine, New York.

Aceon is an angiotensin converting enzyme (ACE) inhibitor, which is approved for the treatment of high blood pressure. Like other ACE inhibitors, it works by blocking the enzyme which converts angiotensin I (an inert substance) to angiotensin II, a hormone which constricts blood vessels and stimulates the release of another hormone called aldosterone, which makes the kidney retain sodium. Both of these effects will tend to raise the blood pressure, so that blocking the formation of angiotensin II will lower the pressure.

Perindopril resembles other ACE inhibitors in it s ability to lower blood pressure. It is a 'pro-drug', which means that it does not become active until it is converted into perindoprilat, which occurs a few hours after the drug is administered. It is effective in once daily dosage. The available strengths are 2, 4 , and 8 milligram tablets. The usual dose is 4 to 16 mgs a day. Like other ACE inhibitors, its main side effect is a dry cough, which occurs in about 10% of patients.

Perindopril is currently being used in a large multinational study called PRAISE, which is designed to see whether adding an ACE inhibitor to the treatment of people who have already had one stroke will help stop them having another.

Aceon is marketed by Solvay.